Navigation Links
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
Date:5/19/2009

>

There was no difference between pirfenidone and placebo in the percentage of patients who experienced a serious adverse event (SAE). An SAE was reported by 35% and 33% of pirfenidone and placebo groups, respectively, in CAPACITY 2 and by 31% and 30%, respectively, in CAPACITY 1. While there was a slightly higher incidence of Grade 3 adverse events in the pirfenidone groups in both studies, there was no difference in overall Grade 4 adverse events between pirfenidone and placebo.

The pattern of adverse events was in general comparable to that observed in previous clinical studies of pirfenidone. The most common adverse events in the pirfenidone group as compared to placebo were nausea (35% vs. 18% in CAPACITY 2 and 38% vs. 16% in CAPACITY 1), rash (31% vs. 10% and 34% vs. 13%), fatigue (28% vs. 21% and 33% vs. 20%), diarrhea (25% vs. 17% and 33% vs. 21%), dyspepsia (17% vs. 9% and 21% vs. 6%), and dizziness (19% vs. 10% and 18% vs. 10%). Rash was generally mild to moderate in both studies; only 2 patients (1 in each CAPACITY study) receiving pirfenidone experienced a severe rash.

ADDITIONAL SAFETY RESULTS REPORTED

The ATS presentation reported new safety data from the CAPACITY studies pertaining to the incidence and cause of deaths, treatment discontinuations due to adverse events and laboratory tests.

Incidence and Cause of Deaths

Analysis of the incidence and cause of death revealed that fewer patients in the pirfenidone 2403 mg group compared with placebo died during the treatment period, defined as the time from the first dose until 28 days after the last dose of study treatment. In CAPACITY 1, 5.3% of patients in the pirfenidone group died during the treatment period, compared with 8.7% in the placebo group. In CAPACITY 2, 5.7% of patients in the pirfenidone group died during the treatment period, compared with 8.0% in the placebo group.

The incidence
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
4. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
5. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
6. AlphaVax Announces Promising Results in Melanoma Studies
7. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
8. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
9. Bionovo Announces First Quarter 2009 Highlights and Financial Results
10. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
11. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DALLAS , July 11, 2014 ... report "Scintillator Market by Composition of Material, Application ... and others), End Product (Personal Instrument, Hand-Held Instruments, ... Forecast and Analysis to 2013 - 2020", published by MarketsandMarkets, ... a CAGR of 5.62% from 2014 to 2020, ...
(Date:7/11/2014)... On Thursday, July 10, ... Dow Jones Industrial Average finished the day 0.42% lower at ... The losses were broad based as eight out of ten ... Care Sector Index ended the day at 711.88, down 0.02%, ... month. Investor-Edge has initiated coverage on the following equities: Covidien ...
(Date:7/11/2014)... LONDON , July 11, 2014 /PRNewswire/ ... of visitors to Safety & Health Expo ... by the move to London ... senior management attending exhibition.     ... (Photo: http://photos.prnewswire.com/prnh/20140711/696892-a ) ...
Breaking Medicine Technology:Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4
... /PRNewswire/ -- Ethicon Endo-Surgery, Inc. today announced ... IDE feasibility trial. The case, which was performed at ... Invasive Surgery, marks the first natural orifice translumenal endoscopic ... NOTES is a surgical method in which external incisions ...
... 9 Approximately ninety-one percent of dentists say patients complaining ... nationwide member survey conducted by the Academy of General Dentistry ... by a decrease in salivary function. It affects approximately ... people at risk for tooth decay. During the Academy of ...
Cached Medicine Technology:First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices 2First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices 3Dry Mouth Linked to Prescription and Over the Counter Drugs 2Dry Mouth Linked to Prescription and Over the Counter Drugs 3
(Date:7/12/2014)... News) -- Burn injuries increase in the summer as people ... experts. Among those most vulnerable to these seasonal fire hazards: ... often get burned by putting their hands on the side ... burn unit at Loyola University Medical Center in Maywood, Ill., ... of ,When you play with fire, you get burned, is ...
(Date:7/12/2014)... Lindsay, ON Canada (PRWEB) July 12, 2014 Sean ... known for throwing out special challenges to his clients. He’s also ... Girls Club. He recently found a way to combine the two ... has raised $2,000 for the Boys and Girls Club. , ... Loss Program, which started on June 23rd. Francis sent out emails ...
(Date:7/12/2014)... Using and carrying around a catheter ... from Ashland, Va., decided that there needed to be ... to conceive of our design," he said. , They ... which provides an inconspicuous way to use and carry ... as promotes comfort and peace of mind. Producible in ...
(Date:7/12/2014)... With prom shopping reaching its final days, VogueQueen.com, ... to showcase its new and trendy apparels. Recently, the ... in its online shop. Additionally, it is now providing ... gowns. According to the company’s sales manager, the promotion ... , He says, “Now, worldwide clients can order ...
(Date:7/12/2014)... Wright & Schulte LLC has filed a DePuy ... of Johnson & Johnson, on behalf of an Ohio man ... metal-on-metal DePuy Pinnacle hip replacement and had to undergo revision ... The DePuy hip lawsuit was filed July 7, 2014, in ... 3:14-cv-2427) where DePuy Pinnacle Hip lawsuit litigation is underway ...
Breaking Medicine News(10 mins):Health News:Burn Injuries More Common in Summer 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5
... people who get lots of vitamin E in their ... those who take in relatively little. Researchers once had high ... important safeguard against heart attacks. But that idea eventually faded ... some think the vitamin may protect against cancer perhaps by ...
... prostate cancer would rather find out sooner than later if ... cancer using the prostate-specific antigen test. But since PSA levels normally ... to know what a high reading is and what may just ... have to undergo repeated biopsies to determine whether they have cancer ...
... a recent study done on rats has shed light on ... brain cell in a rat can make its whiskers twitch, ... controls movement. Eventually this could help scientists develop devices paralyzed ... researchers say they thought that because the part of the ...
... ( an evolution specialist ), helped China's SARS Epidemiology ... fingerprinted virus samples from several dozen infected people and ... provides more evidence that SARS jumps from animals to ... of new cases is crucial, before viral strains have ...
... study shows there may be reason to believe we have ... brain may block unwanted memories. ,Researchers from Stanford University ... were given 36 pairs of unrelated words and asked to ... word pairs into three sets of 12. Participants were asked ...
... research presented at the annual meeting of the Radiological ... accurately detect small cancers and stones in the kidneys, ... ,Multi Detector CT Urography ( MDCTU ) scans can ... through the body from different angles. Patients are given ...
Cached Medicine News:Health News:Vitamin E Found To reduce bladder cancer risk 2Health News:Scientists Have Traced How The SARS Virus evolved 2Health News:CT Scans Said to Accurately Detect Small Cancers 2
... specifically designed for monitoring the performance ... for separation and quantification of cholesterol ... in patient serum samples. Liposure is ... and A (IDL), LDL subfractions, HDL ...
... The Lipoprint System is a high resolution diagnostic ... tested by other methods. The test procedure is ... three hours. Any abnormal value is clearly flagged. ... highly atherogenic, small dense LDL in red and ...
... the only control for monitoring ... synovial fluid samples performed manually ... also an aid for identifying ... a pathological condition present in ...
... Suitable for use with ... BR2 bilirubinometers (pediatric) and all ... instruments including Aeroset, AU Series, ... Vitros. These controls contain purified ...
Medicine Products: